New Key Statistics Module, Z-Score and F-Score
NAS:KRYS Key Ratios
Market Cap $ M | 4,473.36 |
Enterprise Value $ M | 3,949.28 |
P/E(ttm) | 1,743.11 |
PE Ratio without NRI | -- |
Forward PE Ratio | 416.67 |
Price/Book | 5.69 |
Price/Sales | 89.29 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 50.00 |
EPS (TTM) $ | 0.09 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 306.19 |
EV-to-EBITDA | 220.57 |
PEG | -- |
Shares Outstanding M | 28.51 |
Net Margin (%) | 21.56 |
Operating Margin % | -191.77 |
Pre-tax Margin (%) | 25.44 |
Quick Ratio | 17.55 |
Current Ratio | 17.76 |
ROA % (ttm) | 1.62 |
ROE % (ttm) | 1.71 |
ROIC % (ttm) | -47.39 |
Dividend Yield % | -- |
Altman Z-Score | 68.05 |
KRYS Number of Guru Trades
KRYS Volume of Guru Trades
Gurus Latest Trades with NAS:KRYS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KRYS is held by these investors
Total 1
Krystal Biotech Inc Insider Transactions
No Available Data
News about NAS:KRYS
Total 0- 1